Information for immunocompromised individuals regarding prevention and treatment of SARS-CoV-2 infection in the context of currently circulating Omicron sublines — United States, January 2023
BOX. SARS-CoV-2 prevention measures for immunocompromised individuals, their families and close contacts in the context of currently circulating Omicron sublines — United States, January 2023 Because Evusheld is not currently approved for pre-exposure prophylaxis against SARS-CoV-2 infection in the United States, it is important that individuals who are moderately to severely immunocompromised*, those who may …